Mannan-mediated gene delivery for cancer immunotherapy

Area of Science:

• Immunology
• Biotechnology
• Molecular Biology

Background:

• Non-viral delivery systems are crucial for DNA vaccines and gene therapy.
• Mannan, a polysaccharide, has been previously used for protein delivery to antigen-presenting cells.
• Targeting mannose receptors on cells can enhance immune responses.

Purpose of the Study:

• To evaluate oxidized and reduced mannan as ligands for receptor-mediated gene transfer.
• To investigate their efficacy in cancer immunotherapy using DNA vaccines.
• To assess the in vivo immune responses and anti-tumor effects.

Main Methods:

• Complexing DNA encoding ovalbumin (OVA) with oxidized or reduced mannan-poly-L-lysine.
• Administering these complexes to C57BL/6 mice.
• Measuring CD8 and CD4 T-cell responses, antibody production, and tumor protection.

Main Results:

• DNA complexes with oxidized or reduced mannan induced significant CD8 and CD4 T-cell responses.
• Robust antibody responses were observed, leading to protection against OVA+ tumors.
• Mannan-based delivery systems outperformed DNA alone or DNA-poly-L-lysine.

Conclusions:

• Oxidized and reduced mannan are effective for receptor-mediated gene delivery in vivo.
• These mannan derivatives show potential as DNA vaccines for cancer immunotherapy.
• The study highlights the utility of mannan in enhancing gene transfer for therapeutic applications.